Although previous studies have shown that virtually the entire carbon skeleton of dietary glutamate (glutamate-C) is metabolized in the gut for energy production and amino acid synthesis, little is known regarding the fate of dietary glutamate nitrogen (glutamate-N). In this study, we hypothesized that dietary glutamate-N is an effective nitrogen source for amino acid synthesis and investigated the fate of dietary glutamate-N using [ 15 N]glutamate. Fischer male rats were given hourly meals containing [U-
GLUTAMATE IS ONE OF THE MOST ABUNDANT AMINO ACIDS in alimentary proteins. Stoll et al. (21) estimated that 35% of the total energy produced in the intestine is derived from dietary glutamate, whereas the proportion generated from dietary glucose is only 15%. These results suggest that dietary glutamate plays a pivotal role in energy production in the gut. During energy production, most of the carbon skeleton (C) of dietary glutamate is metabolized into CO 2 (50% of the dietary input) or utilized for the intestinal synthesis of alanine, lactate, glutathione, proline, arginine, or other amino acids. Therefore, little glutamate is absorbed into the portal vein (14) , which explains why the systemic concentration of glutamate is low, regardless of the amount that is ingested.
The entry of glutamate-C into the tricarboxylic acid (TCA) cycle requires its deamination, which generates the TCA cycle intermediate ␣-ketoglutarate. Generally, two pathways can be used to perform the deamination step. One reaction is catalyzed by various aminotransferases that use the amino moiety of glutamate to generate amino acids such as alanine, aspartate, and branched-chain amino acids (BCAAs). The other reaction is catalyzed by glutamate dehydrogenase (GDH), which generates ammonia. It has been shown that alanine, citrulline, and other amino acids can be synthesized in the gut (26) , which requires a supply of amino-nitrogen (N). Dietary glutamate-N is a potential source of amino-N, as it can be deaminated via the transamination step. GDH may also be involved in the deamination of dietary glutamate in the gut, since ammonia is produced in the gut after the ingestion of a general diet that is rich in glutamate (15) . Thus, one of the objectives of this study was to clarify the contributions of GDH and aminotransferases in the deamination process of dietary glutamate in the gut.
Glutamate synthesis is a common event in the body. Therefore, glutamate is categorized as a nonessential amino acid (NEAA). However, previous studies have shown that glutamate ingestion is required for general animal growth. Rechcigl et al. (13) found that the removal of NEAAs from the diet suppressed the growth of rats, which indicates the nutritional impact of NEAAs. It was also shown that the addition of glutamate to a NEAA-free diet promoted growth to a greater degree than the addition of other NEAAs. Katagiri and Nakamura (7) proposed that ␣-amino-N is nutritionally essential in mammals and that glutamate is the most effective source of ␣-amino-N. Because most dietary glutamate is metabolized in the gut, it likely does not enter the body's N-pool in its original form. However, there is no direct or quantitative data showing that ␣-amino-N from dietary glutamate is used in the synthesis of circulating amino acids. Therefore, a second objective of our study was to evaluate how dietary glutamate-N is distributed among systemic amino acids.
In this study, the fate of dietary glutamate-C and -N was investigated in rats using stable isotope techniques. Rats were fed diets containing [U- 13 C]glutamate or [ 15 N]glutamate, and the intestinal metabolism of dietary glutamate-C and -N was estimated quantitatively. Furthermore, the incorporation of ingested glutamate-C and -N into systemic amino acids was evaluated.
MATERIALS AND METHODS
Animals and experimental procedures. All experimental procedures were reviewed and approved by the Animal Care Committee of Ajinomoto. Male 6-wk-old Fischer (F344) rats (Charles River Japan, Atsugi, Japan) were maintained under controlled conditions with 12:12-h cycles of dark (1000 -2200) and light (2200 -1000) at 23 Ϯ 1°C and at 55 Ϯ 10% humidity. The rats were fed a purified diet based on AIN-93G containing crystalline amino acids (values in g/kg: arginine, 4.3; histidine, 2.8; isoleucine, 6.2; leucine, 10.7; lysine hydrochloride, 11.5; methionine, 6.5; cysteine, 3.3; phenylalanine, 6.8; tyrosine, 3.4; threonine, 6.2; tryptophan, 2.0; valine, 7.4; alanine, 4.0; aspartate, 4.0; glycine, 6.0; proline, 4.0; serine, 4.0; asparagine monohydrate, 4.6; glutamate, 20.0; and glutamine, 20.0) (Ajinomoto, Tokyo, Japan), following the recommendations of the National Research Council. The rats were adapted to these conditions for 2 wk and were then fed hourly with 1.0 g (ϳ80% of ad libitum intake) of an experimental diet in which half of or all of the natural glutamate was replaced with [U- 13 15 N]glutamate were 49 and 98 mol%, respectively. Feeding of the experimental diets started at 1000 after a 15-h fasting period. The rats were anesthetized by ether after 0, 0.5, 1, 1.5, 3, 6, or 9 h of feeding, and blood was collected simultaneously from the portal vein and the descending aorta. Plasma was separated from other blood components by centrifugation at 3,000 rpm for 20 min at 4°C using EDTA as an anticoagulant. Plasma samples were stored at Ϫ80°C until analysis.
Analysis of isotopic enrichment. The isotopic enrichment of acidic and neutral amino acids in the plasma was measured as reported previously (19) . Briefly, aliquots of plasma were deproteinized with 1 M perchloric acid and then neutralized with KOH. The supernatants were adjusted to pH 4 -6 with 1 M acetic acid and applied to a cation exchange column (AG50W-X8; Bio-Rad Laboratories, Hercules, CA). The amino acids were eluted with 3 M ammonia, and the samples were evaporated with a Speed Vac (Thermo Fisher Scientific, Waltham, MA). The dried samples were then dissolved in water, adjusted to pH 8 with an ammonia solution, and applied to an anion column (AG1-X8; Bio-Rad Laboratories). The neutral amino acids, including glutamine and asparagine, were collected in the flowthrough fractions, and glutamate and aspartate were eluted with 1 M acetic acid. The samples were dried, and n-propyl ester and heptafluorobutyric anhydride (HFBA) derivatives of the amino acids were prepared for GC-MS analysis, as reported previously (19) . Briefly, dried samples were esterified with a 1:4 vol/vol solution of acetyl chloride-1-propanol (Wako, Osaka, Japan) at 80°C for 30 min. After drying, the samples were derivatized with HFBA (Pierce, Rockford, IL) at 60°C for 20 min. For the analysis of the glutamine fractions, the esterification step was performed at room temperature for 2 h. The 13 C and 15 N isotopic enrichments of each amino acid were analyzed with a 6890N gas chromatography system (Agilent Technologies, Waldbrunn, German) equipped with HP-5MS (Agilent Technologies) and 5973N mass spectrometry (Agilent Technologies). Negative ions generated by methane chemical ionization were monitored. The m/z ratios of the monitored ions were glycine (293-295), alanine (307-310), valine (335-340), leucine and isoleucine (349 -354), serine (519 -523), aspartate (393-396), glutamate (407-412), glutamine (346 -351), and proline (333-338). To determine the enrichment of [2- 15 N]glutamine, its deaminated product was analyzed by monitoring ions at m/z ratios of 407 and 408. The 15 N enrichment of plasma ammonia was determined as reported previously (11) . Briefly, plasma ammonia and 2-oxovaleric acid were enzymatically converted to norvaline in the presence of glutamate dehydrogenase (Oriental Yeast, Suita, Osaka). The samples were then loaded onto cation exchange columns, and norvaline was eluted with 1 M acetic acid. After derivatization, the enrichment of n-propyl-HFBA-derivatized norvaline was measured with GC-MS. The ions were monitored at m/z ratios of 186 and 187.
The isotopic enrichment of plasma urea and lactate were determined as reported previously (9, 12) . Briefly, aliquots of plasma were deproteinized by methanol. The dried samples were derivatized with N-methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide (Pierce) at 100°C for 2 h. The isotopic enrichment of the tert-butyldimethylsilyl derivatives was determined by GC-MS. The m/z ratios of the monitored ions were 231-233 for urea and 261-264 for lactate.
The isotopic enrichment of plasma arginine, ornithine, and citrulline was determined using an Agilent 1200 series liquid chromatography system (Agilent Technologies) coupled to triple-quadrupole tandem mass spectrometry (Agilent 6400 series), as reported previously (6) . A 20-l aliquot of plasma was deproteinized with 80 l of methanol; 10-l aliquots of the deproteinized supernatant were mixed with 30 l of 0.2 M sodium borate buffer at pH 8.8; 10 l of AQC reagent was added to the solution, and the mixture was heated at 55°C for 10 min, after which 200 l of 0.2% aqueous formic acid was added to the reaction mixture. AQC-derivatized amino acids were injected into an Ascentis Express C18 HPLC column (2.7-m particle size, L ϫ ID 15 cm ϫ 2.1 mm; SUPELCO). Mobile phase A consisted of 25 mM formic acid in Milli-Q water (pH 6.0 adjusted with ammonia), and mobile phase B consisted of 60% acetonitrile in Milli-Q water (vol/vol). The electroionspray interface was operated in the positive mode at 4,000 V. Quantitative analyses of the amino acids were performed by multiple reaction monitoring. The monitored m/z ratios for the ions (precursor ion/product ion) were arginine (345-352/171), citrulline (346 -352/171), and ornithine (473-478/171).
The isotopic enrichment of blood CO2 was measured as follows. Each whole blood sample was added to a vacuum tube containing 2 N HCl to obtain CO2 gas samples in the head space. The isotopic ratios of the CO2 gases were measured by isotope ratio mass spectrometry (DELTA plus XP; Thermo Fischer Scientific, San Jose, CA) coupled with gas chromatography (Gasbench; Thermo Fischer Scientific) and a gas autosampler (GC-PAL; CTC Analytics, Zwingen, Switzerland).
Measurement of amino acids and other metabolite concentrations. The concentrations of plasma amino acids were determined using an amino acid analyzer (L-8000; Hitachi, Tokyo, Japan) after deproteinization with 5% trichloroacetic acid. CO 2 concentrations in whole blood were measured with an ABL3 blood gas analyzer (Radiometer, Copenhagen, Denmark). The concentration of plasma lactate was measured by Lactate Pro (Arkray, Kyoto, Japan).
Measurement of portal blood flow. Portal blood flow measurements were obtained for each rat fed the experimental diet. Following ether anesthesia, the portal vein was exposed, and the portal blood (venous) flow was measured with a transit-time ultrasonic volume flowmeter (Model T 206 Small Animal Flowmeter; Transonic Systems, Ithaca, NY) and a specific perivascular flow probe, as reported previously (20) . The mean portal venous flow was 11.8 Ϯ 3.3 ml/min (n ϭ 8), which was similar to the value in a previous report (4) .
Calculations. The net release of each amino acid from the portaldrained viscera (PDV) into the portal vein [portal-arterial balance (PA balance), mol/h] was calculated as follows:
Here, Cp and Ca are the concentrations (mol/l) of each amino acid in the portal and arterial blood, respectively, and PF is the portal plasma flow (l/min). The PF was calculated by correcting the blood flow for hematocrit 0.42 [PF ϭ blood flow ϫ (1-0.42)]. The portalarterial balance of CO 2 was calculated using the portal whole blood flow.
Assuming that bioavailability of dietary amino acids is 100%, the postprandial increase in the net release of each metabolite from the PDV into the portal vein (%dietary input) was calculated as follows:
Postprandial PA increase ϭ PA balance fed Ϫ PA balance fasting I diet .
Here, PA balance fasting and PA balancefed are the portal-arterial balances (mol/h) of the fasting rats (before feeding) and the fed rats (9 h of feeding), respectively. I diet (input; mol/h) is the dietary input of each amino acid per hour.
The isotopic enrichment [IE; molecular percent excess (mol%)] of each amino acid was calculated from the tracer-tracee ratio (TTR) as follows:
The TTR of each isotopomer (M ϩ 1, M ϩ 2, M ϩ 3, . . .) for multiple labeled compounds was corrected according to a previous report (17) . The isotopic enrichment of 13 C was adjusted according to the dietary enrichment of glutamate, assuming that all of the ingested glutamate was labeled with 13 C. All of the values for the 13 C-labeled metabolites were calculated using the adjusted enrichments.
The net release of each labeled isotopomer from the PDV into the portal vein (PA balance*, mol/h) was calculated as follows:
Here, Cp and Ca are the concentrations (mol/l) of each amino acid, and Ep and Ea are the isotopic enrichments of each isotopomer in the portal and arterial blood samples, respectively. The same PF value (portal plasma flow, l/min) as described above was used. The hypothetical 13 C and 15 N enrichment for each individual metabolite that was released from the PDV was calculated by dividing the PA balance* by the respective PA balance value, assuming that the net release of each metabolite was equal to the actual release.
To estimate the distribution of dietary glutamate-C into each metabolite released from the PDV, the average 13 C enrichment of all of the carbon in the target molecule (IET), referred to as molecular carbon labeling in a previous study (1) , was calculated using the IE of each isotopomer (M ϩ 1, M ϩ 2, . . . , M ϩ n) as follows:
Here, n is the total number of carbon atoms in the molecule.
Assuming that the isotopic enrichment of [U- 13 C]glutamate in the PDV (i.e., the 13 C enrichment of the precursor pool) reached the steady state after 9 h of feeding, the fractional distribution of dietary glutamate-C into each metabolite released from the PDV (FDC; %dietary input) was estimated as follows:
5 ϫ I label, 13 C .
Here, IET,p and IET,a are the molecular carbon labeling (IET) values of the intended metabolite in the portal and arterial blood samples, respectively; n is the total number of carbon atoms in the molecule, and I label,13C (mol/h) is the dietary input of [U- 13 C]glutamate per hour.
Similarly, the average 15 N enrichment for all of the nitrogen present in the target molecule (IET) was calculated. The fractional distribution of dietary glutamate-N (FDN; %dietary input) was estimated as follows: Data analysis. The data are presented as means Ϯ SD. Differences were analyzed using GraphPad Prism 5 (GraphPad Software, La Jolla, CA) and a Student's t-test or a one-way analysis of variance test followed by Tukey's test.
RESULTS
Amino acid concentrations and PA balance before and after feeding. The amino acid concentrations in the arterial and portal plasma samples that were obtained after a 9-h feeding period were compared with the samples obtained before feeding (following a 15-h fasting period; Table 1 ). We found that the portal and arterial concentrations of alanine, asparagine, proline, BCAA, arginine, urea, and lactate increased after 9 h of feeding. The net release of most of the amino acids from the PDV (expressed as the PA balance) also increased significantly after feeding. The increases in the PA balance of proline, glutamine, asparagine, lysine, serine, threonine, and glycine Data are expressed as means Ϯ SD (n ϭ 4). PDV, portal-drained viscera; PA, portal-arterial. The concentrations of each amino acid, urea, CO2, lactate, and NH3 in the arterial and portal plasma were measured in rats before feeding (fasting) and after 9 h of hourly feeding (fed). The net release of each metabolite from the PDV (i.e., PA balance) was calculated using the portal and arterial concentration differences for each metabolite and portal blood flow measurements. Postprandial PA increases are PA balance differences expressed in terms of the %intake of individual amino acids. †Units are in mM (portal and arterial concentrations) or mmol/h (PA balance). * and **Fed values that are significantly different from the fasting values (*P Ͻ 0.05 and **P Ͻ 0.01, Student's t-test).
after meals accounted for Ͼ50% of the dietary input for these amino acids; however, the glutamate concentration in the portal and arterial blood did not change with feeding. Although there was a significant increase in the PA balance of glutamate after feeding, this increase accounted for only 15% of the dietary input for this amino acid. The PA balance of alanine was elevated remarkably after feeding, and the increase accounted for nearly four times the dietary input for this amino acid.
Steady-state isotopic enrichment of glutamate and additional metabolites in arterial and portal blood. Isotopic enrichment of [U- 13 C]glutamate and [ 15 N]glutamate in the portal and arterial blood increased immediately after the initiation of hourly feeding of experimental diets containing labeled glutamate, and a plateau phase was reached after 1 h of feeding (Fig. 1, A (Fig. 1, B, C , E, and F, respectively). There were no significant differences in the isotopic enrichment values observed after 6 or 9 h of feeding, which indicates that a steady state was achieved after a 6-h feeding period.
The fate of 13 C and 15 N in dietary glutamate in the PDV. To determine the PA balances, the entry of 13 C into each metabolite in the arterial and portal plasma was measured in rats that were fed the [U-
13 C]glutamate-containing diet for 9 h ( Table  2 ). The PA balance of 13 CO 2 (372 Ϯ 85 mol/min) was much greater than that of any other 13 C-labeled metabolite. From the PA balance of each 13 C-labeled metabolite, the fractional distribution of dietary glutamate-C to each metabolite released from the PDV (i.e., the fate of dietary glutamate-C in the PDV) was estimated ( Fig. 2A) . Approximately one-half of the dietary 15 N-labeled isotopomers from the PDV (PA balance, mol/h) was calculated using the concentration of each isotopomer in the portal and arterial plasma samples and the portal blood flow measurements. The isotopic enrichments were adjusted according to the dietary enrichment of glutamate, assuming that all of the ingested glutamate was labeled with 13 C or 15 N.
glutamate-C was metabolized and released into the portal vein as CO 2 , and 13, 12, and 3% were released as lactate, alanine, and proline, respectively. The amount of dietary glutamate-C that was released from the PDV as glutamate (i.e., without metabolism) was minor (8%). The distribution of the 13 C isotopomers was specific for each metabolite. The greater PA balances of the M ϩ 5 isotopomers of glutamine, proline, and ornithine compared with the lighter isotopomers (i.e., M ϩ 1, M ϩ 2, M ϩ 3, and M ϩ 4) indicated the direct entry of five carbons from dietary glutamate into these amino acids. The heaviest isotopomers were also dominant for aspartate, alanine, and lactate, whereas the M ϩ 1 isotopomers were dominant for glycine and serine (data not shown). Most of the 13 C-labeled citrulline released from the PDV was M ϩ 1 or M ϩ 5 isotopomers.
Similarly, the fate of dietary glutamate-N was traced in rats that were fed the [ 15 N]glutamate-containing diet. The PA balance of [ 15 N]alanine was much greater than that of any other 15 N-labeled metabolite ( Table 2 ). The fractional distribution of dietary glutamate-N in the PDV was estimated from the PA balances of these 15 N-labeled metabolites. Threequarters of the dietary glutamate-N was incorporated into alanine, and most of the remainder was incorporated into other amino acids such as citrulline, arginine, proline, serine, or glycine (Fig. 2B) . Only a minor amount of glutamate-N was released as ammonia (2%) or glutamate (3%). An analysis of multiple isotopomers for [ 15 The hypothetical 13 C and 15 N enrichment of metabolites released from the PDV. The hypothetical enrichment of the individually labeled isotopomers that were released from the PDV was estimated from the net release of the labeled and nonlabeled isotopomers for each metabolite (assuming that the net release is equal to the actual release, as is described in MATERIALS AND METHODS; Table 3 ). The enrichment of 13 (Tables 1 and 2 ), assuming that the net release and actual release values are equal. The total is the sum of the enrichment of all of the labeled isotopomers for each metabolite. The isotopic enrichments were adjusted according to the dietary enrichment of glutamate, assuming that all of the ingested glutamate was labeled with 13 C or 15 N.
M ϩ 1, M ϩ 2, and M ϩ 3) and [ 15 N]alanine was 13 and 42%, respectively, which indicates a substantial contribution of dietary glutamate-C and -N to alanine production in the PDV. The hypothetical 13 C and 15 N enrichments of urea cycle metabolites (sum of the enrichment of all of the labeled isotopomers) were 30 and 39% for ornithine and 22 and 34% for citrulline, respectively. These findings further indicate that dietary glutamate is a significant C and N source for the synthesis of these amino acids in the PDV.
The incorporation of dietary glutamate-C and -N into systemic amino acids.
The contributions of dietary glutamate-C and -N to circulating amino acids in the arterial plasma were estimated from the steady-state 13 C and 15 N enrichment of each amino acid after a 9-h labeling period (Fig. 3) . Approximately 17% of the arterial alanine was labeled with 15 N, indicating 17% of circulating alanine-N derived from dietary glutamate. The sum of the 15 N enrichment of citrulline (M ϩ 1, M ϩ 2, and M ϩ 3) was 23%, which indicates that nearly one-quarter of the circulating citrulline was synthesized using dietary glutamate-N. The sums of the 15 N enrichment for arginine and ornithine were as high as 8.8 and 12.8%, respectively, which indicates that dietary glutamate-N is an important source of N for the synthesis of these circulating urea cycle amino acids. Dietary glutamate-N was also incorporated into glutamine, proline, aspartate, glycine, and serine. The 15 N enrichment for these amino acids was 11.3 (sum of M ϩ 1 and M ϩ 2), 4.0, 1.4, 1.3, and 2.9%, respectively. Dietary glutamate-C was also incorporated into various additional amino acids (Fig. 3) . The sums of the 13 C enrichment for the labeled isotopomers of alanine, glutamine, proline, arginine, ornithine, and citrulline were 3.8, 4.5, 5.0, 4.9, 9.0, and 16.0%, respectively. Although the 13 C enrichment was generally less than the 15 N enrichment, these substantial incorporations indicate that dietary glutamate-C is an important source for the synthesis of many circulating amino acids. Table 4 shows the distribution of 13 C and 15 N among the isotopomers of each amino acid found in the arterial plasma. Table 4 .
C and 15 N enrichment of the labeled isotopomers of arterial metabolites
Isotopic Enrichment in Arterial Blood, mol% 13 C labeled 15 N labeled 15 N enrichment (mol%) of the labeled isotopomers of arterial metabolites is shown. The isotopic enrichments were adjusted according to the dietary enrichment of glutamate, assuming that all of the ingested glutamate was labeled with 13 C or 15 N.
The M ϩ 5 isotopomers were dominant in 13 C-labeled proline and ornithine, whereas the M ϩ 1 and M ϩ 5 isotopomers were dominant in 13 C-labeled citrulline. The M ϩ 1/M ϩ 5 ratios for arterial proline, ornithine, and citrulline were 0.41, 0.15, and 1.10, respectively, which were similar to the ratios of the PA balances (0.37, 0.19, and 1.13, respectively). The 13 C isotopomer distribution observed for arterial arginine was similar to that observed for arterial citrulline. Regarding the 15 N isotopomer distribution, M ϩ 2 and M ϩ 3 isotopomers were detected in 15 N-labeled ornithine and citrulline in the arterial plasma, which suggests that multiple pathways permit the entry of dietary glutamate-N into these amino acids.
DISCUSSION
In this study, the metabolism of dietary glutamate-C and -N in the intestine was estimated using stable isotope techniques in rats. Tracer studies using [U- 13 C]glutamate and [ 15 N]glutamate indicated that dietary glutamate was readily and actively metabolized in the PDV.
Utilization of dietary glutamate-C for energy production in the gut. Dietary glutamate-C was metabolized mainly into CO 2 (56% of the ingested glutamate), lactate (13%), and alanine (12%) in the gut. In contrast, only a minor portion (8%) of dietary glutamate was taken up into the portal blood in its nonmetabolized form. Indeed, the glutamate concentrations in the portal and arterial plasma did not increase after feeding, although glutamate was one of the most abundant amino acids in the experimental diet. According to our estimates of the net 13 CO 2 release from the PDV, CO 2 derived from dietary glutamate accounted for 8% of the total CO 2 production in the PDV, which indicates the importance of dietary glutamate in energy production as well as systemic glutamine, enteral, and systemic glucose (21) . The generation of aspartate, alanine, and lactate from the carbon skeleton of glutamate also contributes to energy production, as it involves the conversion of ␣-ketoglutarate to oxaloacetate in the TCA cycle. Here, one molecule of glutamate can theoretically generate 7.5 ATP molecules through this process. Because the absorption of dietary glutamate reportedly takes place in the small intestine (5), the absorptive tissues would have a higher dependency on dietary glutamate for energy production than the remainder of the PDV. Thus, the present results suggest a crucial role of dietary glutamate as an energy source, particularly in the small intestine. The active metabolism of dietary glutamate in the PDV also would help to maintain a constant concentration of glutamate in the circulation regardless of the level of ingestion. Our current results are in agreement with previous findings in piglets (14) and in human infants (16) , which indicates that the first-pass metabolism of dietary glutamate is highly conserved among species.
Deamination step of dietary glutamate-N in the PDV. The deamination of glutamate to ␣-ketoglutarate is the first step in the metabolism of its carbon skeleton. The PA balances of 15 N-labeled amino acids in rats fed [ 15 N]glutamate indicated that a large portion of the dietary glutamate-N was transaminated to form other amino acids in the PDV. Three-quarters of dietary glutamate-N was transaminated to alanine, and 3% was transaminated to serine, glycine aspartate, BCAAs, and other amino acids. Dietary glutamate-N was also utilized for the direct synthesis of proline, which does not require the transamination reaction (Fig. 4) . The PA balance of the M ϩ 2 isotopomer of ornithine indicated that dietary glutamate supplied ␣-and ␦-amino-Ns for ornithine synthesis in the PDV via transamination-independent and -dependent pathways (Fig. 4) . Although glutamate can be deaminated into ␣-ketoglutarate and ammonia by GDH, the PA balance of [
15 N]ammonia accounted for only 2% of the dietary 15 N input. Therefore, these results indicate that, compared with the transamination reactions, GDH does not contribute greatly to the deamination of ingested glutamate. Windmuellar and Spaeth (24) have inferred that dietary glutamate serves as a N-precursor for intestinal alanine synthesis because the luminal administration Glutamate nitrogen is transaminated by some kinds of aminotranferases or oxidized by glutamate dehydrogenase to ammonia, which produces ␣-KG, an intermetabolite of TCA cycle. ␣-KG is oxidized to CO2, which is incorporated into citrulline via CP (*C). Glutamate carbon skeleton is converted directly to urea cycle amino acids via GSA. NH3 released from glutamate is incorporated into ureido-N of citrulline (°), and aspartate-N is incorporated into guanido-N of arginine (OE). Pathways for arginine and urea synthesis located in the liver were also included in the scheme.
of glutamate causes a substantial increase in the concentration of alanine but not ammonia in the venous plasma. Using a stable isotope tracer, our current study directly shows the fate of dietary glutamate-N. Contribution of dietary glutamate on alanine synthesis in the gut. The postprandial increase in the net release of alanine from the PDV was four times greater than the dietary input of alanine. This increased net release would contribute at least partially to a postprandial increase in alanine concentrations in the plasma. The significant incorporation of 13 C and 15 N (i.e., dietary glutamate-C and -N) into circulating alanine also supports this conclusion, as a substantial amount of 13 C-and 15 N-labeled alanine was released from the PDV. In the present study, the steady-state 13 C (sum of labeled isotopomers) and 15 N enrichment of alanine that was released from the PDV in the fed state was estimated to be 12.7 and 41.5%, respectively, suggesting that both 13 and 42% of alanine released from the PDV are synthesized using dietary glutmate-C and -N, respectively. Assuming that all of the labeled circulating alanine [ 13 C and 15 N enrichment of 3.8 (sum of all labeled isotopomers) and 16.8%, respectively] was derived from the PDV, the contribution of the PDV to the whole body alanine flux was estimated to reach 30-40% (3.8/12.7 ϭ 30% for alanine-C and 16.8/41.5 ϭ 40% for alanine-N). Previous studies have demonstrated alanine production in muscle using glucose as a C-precursor, and alanine is also utilized in the liver for gluconeogenesis (18) . This interorgan (muscle to liver) metabolism of amino acids is known as the glucose-alanine cycle. The present study suggests that the PDV also contributes substantially to the whole body alanine flux. Although there could be some production of [ 15 N]alanine in other organs, this portion would be small, since arterial enrichment of [
15 N]alanine is higher than any other amino acids (data not shown). Previous studies have shown that BCAAs can serve as N sources for the synthesis of alanine in muscles (18) . In contrast, the major N source for alanine synthesis in the PDV appears to be dietary glutamate.
Contribution of dietary glutamate on the synthesis of urea cycle amino acids. The small intestine is considered to play an important role in the maintenance of circulating arginine levels. The small intestine produces and releases citrulline into the circulation (27) , which is taken up by the kidneys for the synthesis of arginine (2, 3) . Thus, the positive PA balance of citrulline in the present study reflects its synthesis in the small intestine. Both dietary glutamate-C and -N were incorporated into the citrulline that was released from the PDV, which suggests the importance of dietary glutamate as a C and N source for citrulline synthesis in the gut. The sums of the 13 C (M ϩ 1, M ϩ 2, M ϩ 3, M ϩ 4, and M ϩ 5) and 15 N (M ϩ 1, M ϩ 2, and M ϩ 3) enrichment of citrulline that was released from the PDV were 22 and 34%, respectively. Ornithine, which is a precursor for citrulline synthesis that is released from the PDV, was also labeled with 13 C and 15 N that originated from dietary glutamate. Here, the sums of the 13 C (M ϩ 1, M ϩ 2, M ϩ 3, M ϩ 4, and M ϩ 5) and 15 N (M ϩ 1 and M ϩ 2) enrichment were 15 and 39%, respectively. The substantial incorporation of dietary glutamate-C and -N into circulating citrulline and ornithine in the arterial plasma was also evident in the present study. Although the PA balances of the 13 C-and 15 N-labeled arginine isotopomers were almost zero, a substantial amount of circulating arginine was found to be labeled with 13 C (particularly M ϩ 1 and M ϩ 5) and 15 N.
These results reflect that citrulline produced in the gut is used for the synthesis of arginine and indicate that dietary glutamate contributes to the maintenance of systemic arginine levels by providing C and N. The major 13 C-labeled molecules for ornithine and citrulline were their M ϩ 5 isotopomers, which indicates that the C-skeleton of dietary glutamate was incorporated into ornithine and citrulline via glutamate-semialdehyde. The level of the M ϩ 1 isotopomer of [ 13 C]citrulline was higher than that of the M ϩ 1 isotopomer of [ 13 C]ornithine, which suggests that the 13 C in citrulline was incorporated via citrulline synthetase, which acts on carbamoyl phosphate, a molecule that contains [U- 13 C]glutamate-derived 13 CO 2 . The existence of the M ϩ 3 isotopomer for 15 N-labeled citrulline indicates that dietary glutamate-N entered into all three of the N-groups of citrulline (␣, ␦, and ureido). Although Murphy et al. (10) showed that the gastric infusion of [U- 14 C]glutamate resulted in the labeling of plasma citrulline in neonatal pigs, little has been reported regarding the contribution of dietary glutamate to the synthesis of citrulline in the intestine. The present study is the first to report that dietary glutamate plays a substantial role in the synthesis of citrulline in the gut by serving as a C-source, via glutamate-semialdehyde, and also as an N-source. Previous studies have shown that circulating glutamine, but not enteral glutamine, is a good C-precursor for intestinal citrulline synthesis (8, 22, 25) . Although the role of dietary glutamate as a C-and N-precursor for the intestinal synthesis of citrulline was discussed here, the PA balance of citrulline in the fasting period was similar to that in the fed state, which indicates that citrulline is also synthesized during the fasting period. Therefore, circulating glutamine may be an important precursor during the fasting period. It has been shown that dietary proline is also important for the intestinal synthesis of citrulline (23) . Further studies are required to more clearly outline the roles of the individual amino acids in the intestinal synthesis of citrulline.
Incorporation of dietary glutamate-N into circulating amino acids. This study revealed that dietary glutamate-N was distributed extensively into circulating amino acids such as alanine, the urea cycle amino acids, and essential amino acids such as the BCAAs. Furthermore, the contribution of dietary glutamate as an N source was generally greater than that of glutamate-C for many circulating amino acids. Since transamination reactions are generally bidirectional, extensive distribution of dietary glutamate-N in circulating amino acids in part might only be due to N-exchange via transamination. However, all of the results indicating positive PA balance in alanine, ornithine, and citrulline over their intake levels, disappearance of dietary glutamate-N, and its N-entry into these amino acids in the PDV strongly suggest nutritional significance of glutamate as an N source for their synthesis. As described in the introduction, Katagiri and Nakamura (7) discussed the importance of a dietary supply of glutamate-derived ␣-amino-N for the synthesis of various nonessential amino acids. However, until now there has been no direct evidence that this process actually occurs. The present study would be the first quantitative evidence indicating distribution of dietary glutamate-N into ␣-amino-N of various amino acids in the circulation. The growth-promoting activity of glutamate in rodents was reportedly greater than that of any other nonessential amino acid or inorganic N-source (such as urea), which suggests that dietary glutamate is an efficient N-source (4) and is consistent with our observation that dietary glutamate-N is distributed extensively to circulating amino acids with quantitative significance.
Conclusions. In conclusion, using [U- 13 C]-and [ 15 N]glutamate, this study demonstrated a crucial role of dietary glutamate for energy production and for the synthesis of various amino acids in the PDV. Most of the ingested glutamate was utilized in the PDV, and only a minor portion was released into the portal plasma, thus allowing the body to maintain a constant concentration of glutamate in the circulation. Furthermore, this study showed that dietary glutamate was distributed extensively in various amino acids throughout the body. Although glutamate is a nonessential amino acid that is synthesized in the body at a high rate, our data suggest that dietary glutamate is an important nutritional source of C and N. Further studies are needed to determine whether other nonessential amino acids function as N or C sources and whether they do so to the same degree as glutamate.
